Element Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,429
Closed -$1.15M 67
2023
Q3
$1.15M Sell
9,429
-5,615
-37% -$748K 0.1% 191
2023
Q2
$2.11M Buy
15,044
+784
+5% +$108K 0.14% 162
2023
Q1
$2.02M Buy
+14,260
New +$2.04M 0.15% 128
2022
Q1
Sell
-66,249
Closed -$11.5M 142
2021
Q4
$11.5M Buy
+66,249
New +$10.1M 0.74% 30
2019
Q4
Sell
-11,054
Closed -$1.18M 90
2019
Q3
$1.18M Buy
+11,054
New +$1.13M 0.1% 173
2018
Q2
Sell
-150,019
Closed -$15M 867
2018
Q1
$15M Sell
150,019
-299,520
-67% -$30.7M 0.35% 62
2017
Q4
$44.3M Buy
+449,539
New +$42.6M 0.91% 27
2016
Q3
Sell
-13,404
Closed -$1.09M 93
2016
Q2
$1.09M Buy
13,404
+4,357
+48% +$332K 0.16% 91
2016
Q1
$646K Buy
9,047
+3,677
+68% +$247K 0.1% 154
2015
Q4
$382K Buy
5,370
+1,200
+29% +$80.7K 0.07% 151
2015
Q3
$256K Buy
4,170
+3,070
+279% +$215K 0.09% 109
2015
Q2
$79.8K Buy
+1,100
New +$81.2K 0.03% 215

Other funds holding DGX

Element Capital Management's DGX Position: Q4 2023 in Review

Element Capital Management sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 9,429 shares — an estimated $1.15M sold.

Element Capital Management first reported a position in DGX in Q2 2015 and held it in 12 quarters. The position peaked at $44.3M in Q4 2017. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

  • Element Capital Management reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
  • Element Capital Management sold 9,429 Quest Diagnostics shares in Q4 2023, an estimated $1.15M.
  • Element Capital Management first reported a position in Quest Diagnostics in Q2 2015 and held it in 12 quarters.
  • Element Capital Management's Quest Diagnostics position peaked at $44.3M in Q4 2017.
  • 827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.